Skip to main content

Advertisement

SpringerLink
Log in

Disappearance of bulky diffuse large B-cell lymphoma after methotrexate/infliximab withdrawal

  • Images in Hematology
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tokuhira M, Tamaru JI, Kizaki M. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop. 2019;59:72–92.

    Article  Google Scholar 

  2. Tokuhira M, Tanaka Y, Takahashi Y, Kimura Y, Tomikawa T, Anan T, et al. The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate—associated lymphoproliferative disorders. J Clin Exp Hematop. 2020;60:41–50.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Hematology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan

    Hiroyuki Takamatsu & Takeshi Yoroidaka

Authors
  1. Hiroyuki Takamatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takeshi Yoroidaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroyuki Takamatsu.

Ethics declarations

Conflict of interest

There are no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takamatsu, H., Yoroidaka, T. Disappearance of bulky diffuse large B-cell lymphoma after methotrexate/infliximab withdrawal. Int J Hematol 115, 1–2 (2022). https://doi.org/10.1007/s12185-021-03255-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-021-03255-y

Search

Navigation